CT引导下肺芯针活检在血液系统恶性肿瘤患者中安全且比细针穿刺活检更有效
该回顾性研究纳入2007至2017年间166例血液系统恶性肿瘤患者,比较CT引导下肺芯针活检(CNB)与细针穿刺活检(FNAB)的安全性和诊断率。CNB组诊断失败率13%(8/60)显著低于FNAB组的45%(48/106)(P < .0001),并发症发生率无统计学显著差异。结论认为CNB诊断率更高,出血并发症和气胸风险虽较高但未达统计学显著。
要点
- 血液系统恶性肿瘤患者肺活检时,CNB诊断失败率13%(8/60)显著低于FNAB的45%(48/106)(P < .0001)。
- CNB组需置入胸管者1.7%、咯血5%、血胸5%,与FNAB组(1.9%、2.8%、2%)相比均无统计学显著差异。
- 诊断性活检后51%患者临床管理改变,非诊断性活检后仅21%改变(P = .0002)。
核心结论
- CT引导下CNB是血液系统恶性肿瘤患者肺活检的有效技术,诊断率高于FNAB。
- CNB出血并发症和气胸风险较高,但未达统计学显著差异。
研究设计与样本
- 回顾性研究,经机构审查委员会批准,回顾2007至2017年间166例诊断为白血病、淋巴瘤或骨髓增生异常综合征(伴或不伴造血干细胞移植)并接受CT引导下肺FNAB和/或CNB的患者。
- 复习患者医疗记录、病理报告和介入活检报告。
- 36%(60/166)的操作包含CNB(CNB+FNAB或仅CNB),64%(106/166)仅行FNAB。
诊断标准与关键数值
- CNB组诊断失败率13%(8/60) vs 仅FNAB组45%(48/106)(P < .0001)。
- CNB组需胸管置入1.7% vs 仅FNAB组1.9%(P = .7)。
- CNB组咯血5% vs 仅FNAB组2.8%(P = .4)。
- CNB组血胸5% vs 仅FNAB组2%(P = .3)。
- 诊断性活检者51%临床管理改变 vs 非诊断性活检者21%(P = .0002)。
临床应用与阅片要点
- 在血液系统恶性肿瘤患者肺结节或肿块活检中,CNB可获得更高的诊断率。
- CNB组中92%(55/60)在CNB前也进行了FNAB。
- CNB出血并发症和气胸风险较高,但原文未给出推荐性建议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the safety and diagnostic yield of CT-guided core-needle biopsy (CNB) versus fine-needle aspiration biopsy (FNAB) of lung nodules and masses in patients with hematologic malignancies (HMs).
MATERIALS AND METHODS: With institutional review board approval, 166 patients were retrospectively reviewed between 2007 and 2017 who were diagnosed with leukemia, lymphoma, or myelodysplastic syndromes (with or without hematopoietic stem cell transplant) and who underwent CT-guided FNAB and/or CNB of the lung. Patient medical records, pathologic reports, and interventional biopsy reports were reviewed.
RESULTS: In the study period, 166 patients underwent percutaneous CT-guided lung biopsy; 36% (60 of 166) of the procedures included CNB (CNB + FNAB and CNB only), whereas 64% (106 of 166) were FNAB only. In the CNB group, FNAB was also performed for 92% (55 of 60) of the patients before CNB; 13% (eight of 60) of patients in the CNB group were nondiagnostic versus 45% (48 of 106) of FNAB only (P < .0001). There was no statistically significant difference in the pulmonary complication rates, with 1.7% of CNB and 1.9% of FNAB only requiring chest tube placement (P = .7), 5% of CNB and 2.8% of FNAB only developing hemoptysis (P = .4), and 5% of CNB and 2% of FNAB only developing hemothorax (P = .3). A change in clinical management was observed in 51% of patients with diagnostic biopsies compared with 21% of patients with nondiagnostic biopsies (P = .0002).
CONCLUSION: CT-guided CNB is an effective technique for performing lung biopsy in patients with HMs with higher diagnostic yield compared with FNAB, and a higher, although not a statistically significant, increased risk of bleeding complications and pneumothorax.© RSNA, 2019See also the commentary by Elicker in this issue.
引用
- Watane GV, Hammer MM, Barile MF, et al. CT-guided Core-Needle Biopsy of the Lung Is Safe and More Effective than Fine-Needle Aspiration Biopsy in Patients with Hematologic Malignancies. Radiol Cardiothorac Imaging. 2019. PMID: 33778526. doi:10.1148/ryct.2019180030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。